KIR2DS4 Human Pre-designed siRNA Set A contains three designed siRNAs for KIR2DS4 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

KIR3DL1 Human Pre-designed siRNA Set A contains three designed siRNAs for KIR3DL1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

KIR3DL2 Human Pre-designed siRNA Set A contains three designed siRNAs for KIR3DL2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

KIR3DL3 Human Pre-designed siRNA Set A contains three designed siRNAs for KIR3DL3 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

KIR3DS1 Human Pre-designed siRNA Set A contains three designed siRNAs for KIR3DS1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

KIRREL1 Human Pre-designed siRNA Set A contains three designed siRNAs for KIRREL1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

KIRREL2 Human Pre-designed siRNA Set A contains three designed siRNAs for KIRREL2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

KIRREL3 Human Pre-designed siRNA Set A contains three designed siRNAs for KIRREL3 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

KISS1 Human Pre-designed siRNA Set A contains three designed siRNAs for KISS1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

KISS1R Human Pre-designed siRNA Set A contains three designed siRNAs for KISS1R gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

Kiss1r Mouse Pre-designed siRNA Set A contains three designed siRNAs for Kiss1r gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

Kiss1r Rat Pre-designed siRNA Set A contains three designed siRNAs for Kiss1r gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.

Kiss2 peptide is a positive regulator of reproduction by transducing its activity via PKA and PKC pathways, coupled with its cognate G protein-coupled receptor GPR54[1].

KIT Human Pre-designed siRNA Set A contains three designed siRNAs for KIT gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

Kit Mouse Pre-designed siRNA Set A contains three designed siRNAs for Kit gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

Kit Rat Pre-designed siRNA Set A contains three designed siRNAs for Kit gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.

KITLG Human Pre-designed siRNA Set A contains three designed siRNAs for KITLG gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

KIZ Human Pre-designed siRNA Set A contains three designed siRNAs for KIZ gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

KL Human Pre-designed siRNA Set A contains three designed siRNAs for KL gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

KLA seq acetate is a cell membrane-penetrating α-helical amphipathic model peptide. KLA seq acetate conjugates peptide nucleic acids (PNAs) for delivery to mammalian cells. KLA seq acetate covalently links targeted mRNA and fluorescein to form a delivery system that has low re-export and is less resistant to serum effects[1].

KLA seq acetate is a cell membrane-penetrating α-helical amphipathic model peptide. KLA seq acetate conjugates peptide nucleic acids (PNAs) for delivery to mammalian cells. KLA seq acetate covalently links targeted mRNA and fluorescein to form a delivery system that has low re-export and is less resistant to serum effects[1].

KLA seq acetate is a cell membrane-penetrating α-helical amphipathic model peptide. KLA seq acetate conjugates peptide nucleic acids (PNAs) for delivery to mammalian cells. KLA seq acetate covalently links targeted mRNA and fluorescein to form a delivery system that has low re-export and is less resistant to serum effects[1].

KLB Human Pre-designed siRNA Set A contains three designed siRNAs for KLB gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

KLC1 Human Pre-designed siRNA Set A contains three designed siRNAs for KLC1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

KLC2 Human Pre-designed siRNA Set A contains three designed siRNAs for KLC2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

KLC3 Human Pre-designed siRNA Set A contains three designed siRNAs for KLC3 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

KLC4 Human Pre-designed siRNA Set A contains three designed siRNAs for KLC4 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

KLD-12 TFA is the TFA salt form of KLD-12 (HY-P2263). KLD-12 TFA is a self a 12-residue self-assembling peptide that is used in tissue-engineering. KLD-12 TFA combined with SDF-1 self-assembled polypeptide enhances chondrogenic differentiation of bone marrow stromal cells (BMSCs). KLD-12 TFA hydrogel can fill full-thickness osteochondral defects in situ and improve cartilage repair[1][2][3].

KLD-12 TFA is the TFA salt form of KLD-12 (HY-P2263). KLD-12 TFA is a self a 12-residue self-assembling peptide that is used in tissue-engineering. KLD-12 TFA combined with SDF-1 self-assembled polypeptide enhances chondrogenic differentiation of bone marrow stromal cells (BMSCs). KLD-12 TFA hydrogel can fill full-thickness osteochondral defects in situ and improve cartilage repair[1][2][3].

KLD-12 TFA is the TFA salt form of KLD-12 (HY-P2263). KLD-12 TFA is a self a 12-residue self-assembling peptide that is used in tissue-engineering. KLD-12 TFA combined with SDF-1 self-assembled polypeptide enhances chondrogenic differentiation of bone marrow stromal cells (BMSCs). KLD-12 TFA hydrogel can fill full-thickness osteochondral defects in situ and improve cartilage repair[1][2][3].

KLF1 Human Pre-designed siRNA Set A contains three designed siRNAs for KLF1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

KLF10 Human Pre-designed siRNA Set A contains three designed siRNAs for KLF10 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

KLF10-IN-1 (#48-15) is a KLF10 inhibitor with an IC50 value of 40 μM against the KLF10 reporter gene. KLF10-IN-1 can suppress KLF10-DNA binding and transcriptional activity, block the conversion of CD4+CD25− T cells into CD4+CD25+ T regulatory cells, and downregulate the expression of KLF10 target genes. KLF10-IN-1 can be utilized as a useful mechanistic probe […]

KLF11 Human Pre-designed siRNA Set A contains three designed siRNAs for KLF11 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

KLF12 Human Pre-designed siRNA Set A contains three designed siRNAs for KLF12 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

KLF13 Human Pre-designed siRNA Set A contains three designed siRNAs for KLF13 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

KLF14 Human Pre-designed siRNA Set A contains three designed siRNAs for KLF14 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

KLF15 Human Pre-designed siRNA Set A contains three designed siRNAs for KLF15 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

KLF16 Human Pre-designed siRNA Set A contains three designed siRNAs for KLF16 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

KLF17 Human Pre-designed siRNA Set A contains three designed siRNAs for KLF17 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

KLF2 Human Pre-designed siRNA Set A contains three designed siRNAs for KLF2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

KLF3 Human Pre-designed siRNA Set A contains three designed siRNAs for KLF3 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

KLF4 Human Pre-designed siRNA Set A contains three designed siRNAs for KLF4 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

KLF5 Human Pre-designed siRNA Set A contains three designed siRNAs for KLF5 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

KLF6 Human Pre-designed siRNA Set A contains three designed siRNAs for KLF6 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

KLF7 Human Pre-designed siRNA Set A contains three designed siRNAs for KLF7 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

KLF8 Human Pre-designed siRNA Set A contains three designed siRNAs for KLF8 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

KLF9 Human Pre-designed siRNA Set A contains three designed siRNAs for KLF9 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.